Pfizer’s FDA-approved interchangeable
biosimilar to
Humira® (adalimumab)

Injection: 40 mg/0.8 mL, 20 mg/0.4 mL

ABRILADA. Let’s go.

Proven results Citrate-free Pfizer services & support ABRILADA. Let's go.

Not actual patient.

Person walking
Person walking
Rx script icon

Are you starting treatment with ABRILADA?

TAKE YOUR NEXT STEP

Biosimilar icon

Are you switching to ABRILADA from Humira?

TAKE YOUR NEXT STEP

If eligible, you may pay as little as $0 for ABRILADA treatment.

LEARN MORE

Enrollment required. Limits, terms, and conditions apply.*

ABRILADA IS APPROVED TO

REDUCE THE SIGNS AND SYMPTOMS OF:

hand icon

Moderate to severe rheumatoid arthritis (RA) in adults. ABRILADA can be used alone, with methotrexate, or with certain other medicines. ABRILADA may prevent further damage to your bones and joints and may help your ability to perform daily activities.

child icon

Moderate to severe polyarticular juvenile idiopathic arthritis (JIA) in children 2 years of age and older. ABRILADA can be used alone or with methotrexate.

hand icon

Psoriatic arthritis (PsA) in adults. ABRILADA can be used alone or with certain other medicines. ABRILADA may prevent further damage to your bones and joints and may help your ability to perform daily activities.

lower back icon

Ankylosing spondylitis (AS) in adults.

person icon

Moderate to severe hidradenitis suppurativa (HS) in adults.

TREAT:

intestine icon

Moderate to severe Crohn’s disease (CD) in adults and children 6 years of age and older.

colon icon

Moderate to severe ulcerative colitis (UC) in adults. It is not known if adalimumab products are effective in people who stopped responding to or could not tolerate anti-TNF medicines.

person icon

Moderate to severe chronic plaque psoriasis (Ps) in adults who are ready for systemic therapy or phototherapy, and are under the care of a doctor who will decide if other systemic therapies are less appropriate.

eye icon

Uveitis (UV) in adults: non-infectious intermediate (middle part of the eye), posterior (back of the eye), and panuveitis (all parts of the eye).